Potential of Amifostine for Chemoradiotherapy and Radiotherapy-associated Toxicity Reduction in Advanced NSCLC: A Meta-Analysis

Anticancer research

Volumn 36, Issue 1, 2016, Pages 5-12

  Devine, Annemarie ^a   Marignol, Laure ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Amifostine; chemoradiotherapy; non small cell lung cancer; NSCLC; radiotherapy; review; toxicity

Indexed keywords

AMIFOSTINE; RADIOPROTECTIVE AGENT;

ADVERSE EFFECTS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; CHI SQUARE DISTRIBUTION; HUMAN; LUNG NEOPLASMS; META ANALYSIS; ODDS RATIO; PATHOLOGY; RADIATION INJURIES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

AMIFOSTINE; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; CHI-SQUARE DISTRIBUTION; HUMANS; LUNG NEOPLASMS; ODDS RATIO; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84974806037     PISSN: None     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (0)